Di Salvo, C., D’Antongiovanni, V., Benvenuti, L., Fornai, M., Valdiserra, G., Natale, G., Ryskalin, L., Lucarini, E., Mannelli, L. D. C., Ghelardini, C., Colucci, R., Haskó, G., Pellegrini, C., & Antonioli, L. (2024). The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis. Journal of Drug Targeting, 32(8), 953–963. https://doi.org/10.1080/1061186x.2024.2367563

Horesh, M. E., Martin-Fernandez, M., Gruber, C., Buta, S., Le Voyer, T., Puzenat, E., Lesmana, H., Wu, Y., Richardson, A., Stein, D., Hodeib, S., Youssef, M., Kurowski, J. A., Feuille, E., Pedroza, L. A., Fuleihan, R. L., Haseley, A., Hovnanian, A., Quartier, P., … Bogunovic, D. (2024). Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis. Journal of Experimental Medicine, 221(6). https://doi.org/10.1084/jem.20232387

Van, N. T., Zhang, K., Wigmore, R. M., Kennedy, A. I., DaSilva, C. R., Huang, J., Ambelil, M., Villagomez, J. H., O’Connor, G. J., Longman, R. S., Cao, M., Snook, A. E., Platten, M., Kasenty, G., Sigal, L. J., Prendergast, G. C., & Kim, S. V. (2023). Dietary L-Tryptophan consumption determines the number of colonic regulatory T cells and susceptibility to colitis via GPR15. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-43211-4

Santiago, P., Coelho-Prabhu, N., Lennon, R., Rui, S., Rajauria, P., Friton, J., Raffals, L. E., Deepali, F., Daoud, N., Farraye, F. A., Tuck, J., Malik, T., Leleiko, N. S., Shapiro, J., Shah, S. A., Sands, B. E., & Ungaro, R. C. (2023). Baseline Clinical Factors Are Associated With Risk of Complications in Crohn’s Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway. American Journal of Gastroenterology, 119(1), 147–154. https://doi.org/10.14309/ajg.0000000000002498

Baker, M. E., Fletcher, J. G., Church, J., Hull, T., Dane, B., Huang, C., Flicek, K., & Ream, J. (2023). Future directions in imaging pouches. Abdominal Radiology, 48(9), 3000–3004. https://doi.org/10.1007/s00261-023-03971-5

Shin, A. E., Tesfagiorgis, Y., Larsen, F., Derouet, M., Zeng, P. Y. F., Good, H. J., Zhang, L., Rubinstein, M. R., Han, Y. W., Kerfoot, S. M., Nichols, A. C., Hayakawa, Y., Howlett, C. J., Wang, T. C., & Asfaha, S. (2023). F4/80+Ly6Chigh Macrophages Lead to Cell Plasticity and Cancer Initiation in Colitis. Gastroenterology, 164(4), 593-609.e13. https://doi.org/10.1053/j.gastro.2023.01.002

Hsu, N.-Y., Nayar, S., Gettler, K., Talware, S., Giri, M., Alter, I., Argmann, C., Sabic, K., Thin, T. H., Ko, H.-B. M., Werner, R., Tastad, C., Stappenbeck, T., Azabdaftari, A., Uhlig, H. H., Chuang, L.-S., & Cho, J. H. (2022). NOX1 is essential for TNFα-induced intestinal epithelial ROS secretion and inhibits M cell signatures. Gut, 72(4), 654–662. https://doi.org/10.1136/gutjnl-2021-326305

Lee, K. E., Faye, A. S., Vermeire, S., & Shen, B. (2022). Perioperative Management of Ulcerative Colitis: A Systematic Review. Diseases of the Colon & Rectum, 65(S1), S5–S19. https://doi.org/10.1097/dcr.0000000000002588

D’Antongiovanni, V., Pellegrini, C., Benvenuti, L., Fornai, M., Di Salvo, C., Natale, G., Ryskalin, L., Bertani, L., Lucarini, E., Di Cesare Mannelli, L., Ghelardini, C., Nemeth, Z. H., Haskó, G., & Antonioli, L. (2022). RETRACTED ARTICLE: Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis. Inflammation, 45(4), 1829–1847. https://doi.org/10.1007/s10753-022-01663-8

Yao, M., Fei, Y., Zhang, S., Qiu, B., Zhu, L., Li, F., Berglund, B., Xiao, H., & Li, L. (2022). Gut Microbiota Composition in Relation to the Metabolism of Oral Administrated Resveratrol. Nutrients, 14(5), 1013. https://doi.org/10.3390/nu14051013

Varma, S., Green, P. H., & Krishnareddy, S. (2022). Clinical Factors Associated With Positive Stool PCR for Gastrointestinal Pathogens in Celiac and Inflammatory Bowel Disease. Journal of Clinical Gastroenterology, 56(3), e196–e202. https://doi.org/10.1097/mcg.0000000000001657

Shi, C., Dawulieti, J., Shi, F., Yang, C., Qin, Q., Shi, T., Wang, L., Hu, H., Sun, M., Ren, L., Chen, F., Zhao, Y., Liu, F., Li, M., Mu, L., Liu, D., Shao, D., Leong, K. W., & She, J. (2022). A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease. Science Advances, 8(4). https://doi.org/10.1126/sciadv.abj2372